Related Experiment Video
Updated: May 25, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
FTO and obesity: a problem for a billion people
1Metabolic Research Labs, Institute of Metabolic Science, University of Cambridge, Cambridge, UK. gshy2@cam.ac.uk
Journal of Neuroendocrinology
|January 18, 2012
Summary
Obesity stems from consuming excess energy. Genetic variations in the fat mass and obesity-associated (FTO) gene are strongly linked to obesity and increased food intake across diverse populations.
Area of Science:
- Genetics and Obesity Research
Background:
- Obesity is a complex condition resulting from an energy imbalance.
- Understanding the genetic factors influencing appetite and food intake is crucial for addressing the obesity epidemic.
Purpose of the Study:
- To investigate the association between genetic variations in the fat mass and obesity-associated (FTO) gene and obesity.
- To explore the role of FTO gene variations in regulating food intake.
Main Methods:
- Genetic analyses were performed to identify variations in the FTO gene.
- The association between FTO gene variations and obesity/food intake was examined across different age groups and populations.
Main Results:
- Significant associations were found between variations in the FTO gene and obesity.
- FTO gene variations were robustly linked to increased food intake.
Conclusions:
- The FTO gene plays a significant role in the development of obesity.
- Further research into the complex biology of FTO is warranted to understand its mechanisms in regulating appetite and body weight.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Metabolic States of the Body: Fasting and Starvation
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...